November 16, 2023 eCOA Holds Annual Meeting in Denmark C-Path’s eCOA Consortium convened in Copenhagen, Denmark for its EU face-to-face meeting on Thursday, November 16. The eCOA...
November 16, 2023 Poster: C-Path’s Translational Therapeutics Accelerator: A Unique Solution to Successfully Bridge the Valley of Death in Academic Drug Discovery and Development
November 16, 2023 VCP Disease(s), an Integrated Approach to Neurodegenerative Disorders In this webinar from Critical Path Institute’s Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP), speake
November 9, 2023 C-Path’s Pioneering Neuroscience Workshop Transforms the Landscape of Neurological Disorder Therapies TUCSON, Ariz., Nov. 9, 2023 – Critical Path Institute (C-Path) is pleased to announce the release of a new peer-reviewed publica
November 8, 2023 C-Path Partners with Unite4TB to Create a New Dawn in the Fight Against Tuberculosis C-Path is proud to be part of UNITE4TB, a public-private partnership funded by the Innovative Medicines Initiative and part of the
November 7, 2023 C-Path’s T1D Consortium New-onset Article Published in The Lancet Diabetes and Endocrinology ype 1 Diabetes Consortium, along with external collaborators from Cardiff University and the University of Alberta, today announce
November 6, 2023 ASN PKDOC Poster — November 2023: Despite the regulatory advances in ADPKD including the qualification of total kidney volume (TKV) as a prognostic enrichment bioma
November 1, 2023-November 3, 2023 Connective Tissue Oncology Society (CTOS) Annual Meeting Members of the CDRC team will join the CTOS at The Convention Centre Dublin in Ireland. The Connective Tissue Oncology Society...
October 30, 2023 eCOA Consortium Announces Publication of an Open Access Article C-Path’s eCOA Consortium is pleased to announce the publication of an open access article in Value in Health titled “Best Prac
